BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36938648)

  • 1. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
    Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
    Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
    Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
    Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
    Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
    Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
    Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
    Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.
    Rom H; Tamir S; Van Vugt JLA; Berger Y; Perl G; Morgenstern S; Tovar A; Brenner B; Benchimol D; Kashtan H; Sadot E
    Ann Surg Oncol; 2022 Mar; 29(3):1553-1563. PubMed ID: 34716836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
    Mitsunaga S; Kasamatsu E; Machii K
    Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma.
    Yanagaki M; Onda S; Gocho T; Igarashi Y; Shirai Y; Okui N; Matsumoto M; Sakamoto T; Haruki K; Ikegami T
    Langenbecks Arch Surg; 2024 Apr; 409(1):130. PubMed ID: 38634913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
    BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cachexia worsens prognosis in patients with resectable pancreatic cancer.
    Bachmann J; Heiligensetzer M; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
    J Gastrointest Surg; 2008 Jul; 12(7):1193-201. PubMed ID: 18347879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
    Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
    Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
    PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer.
    La Vaccara V; Cascone C; Coppola A; Farolfi T; Cammarata R; Emerenziani S; Coppola R; Caputo D
    Ann Ital Chir; 2023; 94():45-51. PubMed ID: 36810297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
    Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
    World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
    Honselmann KC; Elser Y; Boeckmann T; Bolm L; Winkel MT; Deichmann S; Braun R; Wellner UF; Keck T; Lapshyn H
    Surgery; 2023 Sep; 174(3):674-683. PubMed ID: 37349251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.